Nicholas J. Virca
2016
In 2016, Nicholas J. Virca earned a total compensation of $274.1K as President and Chief Executive Officer at HedgePath Pharmaceuticals, a 71% increase compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Salary | $187,500 |
| Other | $11,637 |
| Total | $274,137 |
Virca received $187.5K in salary, accounting for 68% of the total pay in 2016.
Virca also received $75K in bonus and $11.6K in other compensation.
Rankings
In 2016, Nicholas J. Virca's compensation ranked 12,881st out of 14,075 executives tracked by ExecPay. In other words, Virca earned more than 8.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,881 out of 14,075 | 9th |
Division Services | 2,064 out of 2,282 | 10th |
Major group Engineering, Accounting, Research, Management, And Related Services | 164 out of 184 | 11th |
Industry group Research, Development, And Testing Services | 52 out of 59 | 12th |
Industry Commercial Physical and Biological Research | 48 out of 55 | 13th |
Source: SEC filing on November 13, 2017.
Virca's colleagues
We found one more compensation record of an executive who worked with Nicholas J. Virca at HedgePath Pharmaceuticals in 2016.
2016
Garrison Hasara
HedgePath Pharmaceuticals